Savara (SVRA) Enterprise Value (2010 - 2026)
Savara (SVRA) reported Enterprise Value of -$202.8 million for Q1 2026, down 17.52% year-over-year from -$245.9 million in Q1 2025, and up 13.97% quarter-over-quarter from -$235.7 million in Q4 2025.
Savara (SVRA) Enterprise Value (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Enterprise Value data on file, last reported at -$202.8 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$202.8 million, down 17.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$202.8 million (down 17.52% YoY), and the FY2025 annual result was -$235.7 million, down 20.06% from the prior year.
- Enterprise Value climbed to -$202.8 million in Q1 2026 per SVRA's latest filing, from -$235.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$105.1 million in Q2 2023 and troughed at -$235.7 million in Q4 2025.
- A 5-year average of -$156.9 million and a median of -$146.4 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value plunged 30.39% in 2024, then jumped 43.32% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$125.9 million in 2022, then dropped by 28.95% to -$162.3 million in 2023, then retreated by 20.95% to -$196.3 million in 2024, then dropped by 20.06% to -$235.7 million in 2025, then grew by 13.97% to -$202.8 million in 2026.
- Business Quant data shows SVRA's Enterprise Value at -$202.8 million in Q1 2026, -$235.7 million in Q4 2025, and -$124.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | -202.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202.78 Mn |
| Dec 31, 2025 | -235.70 Mn |
| Sep 30, 2025 | -124.39 Mn |
| Jun 30, 2025 | -146.40 Mn |
| Mar 31, 2025 | -172.54 Mn |
| Dec 31, 2024 | -196.33 Mn |
| Sep 30, 2024 | -219.44 Mn |
| Jun 30, 2024 | -121.60 Mn |
| Mar 31, 2024 | -143.10 Mn |
| Dec 31, 2023 | -162.32 Mn |
| Sep 30, 2023 | -168.29 Mn |
| Jun 30, 2023 | -105.10 Mn |
| Mar 31, 2023 | -114.78 Mn |
| Dec 31, 2022 | -125.88 Mn |
| Sep 30, 2022 | -134.04 Mn |
| Jun 30, 2022 | -142.45 Mn |
| Mar 31, 2022 | -151.80 Mn |
| Dec 31, 2021 | -161.17 Mn |
| Sep 30, 2021 | -170.80 Mn |
| Jun 30, 2021 | -180.70 Mn |